Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells

Experimental Cell Research

Volumn 282, Issue 2, 2003, Pages 121-131

  Ewald, Jonathan A ^a,c   Wilkinson, John C ^a,d   Guyer, Cheryl A ^a   Staros, James V ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 3; LIGAND; MUTANT PROTEIN; PHOSPHOTRANSFERASE; PROTEIN DERIVATIVE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CATTLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE MUTATION; HEMATOPOIETIC CELL; LIGAND BINDING; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REGULATORY MECHANISM; SERUM;

BOVINAE; MURINAE;

EID: 0037440471     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00014-9     Document Type: Article

References (62)

1. Wells A. EGF receptor. Int. J. Biochem. Cell Biol. 31:1999;637-643.
2. van der Geer P., Hunter T., Lindberg R.A. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10:1994;251-337.
3. Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 9:1992;383-391.
4. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
5. Adamson E.D., Wiley L.M. The EGFR gene family in embryonic cell activities. Curr. Top. Dev. Biol. 35:1997;71-120.
6. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. The ErbB signaling network Receptor heterodimerization in development and cancer . EMBO J. 19:2000;3159-3167.
7. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:2001;127-137.
8. Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell. 80:1995;213-223.
9. Russo M.W., Lukas T.J., Cohen S., Staros J.V. Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase. J. Biol. Chem. 260:1985;5205-5208.
10. Trafny Madhusudan E.A., Xuong N.H., Adams J.A., Ten Eyek L.F., Taylor S.S., Sowadski J.M. cAMP-dependent protein kinase Crystallographic insights into substrate recognition and phosphotransfer . Protein Sci. 3:1994;176-187.
11. Coker K.J., Staros J.V., Guyer C.A. A kinase-negative epidermal growth factor receptor that retains the capacity to stimulate DNA synthesis. Proc. Natl. Acad. Sci. USA. 91:1994;6967-6971.
12. Honegger A.M., Szapary D., Schmidt A., Lyall R., Van Obberghen E., Dull T.J., Ullrich A., Schlessinger J. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis. Mol. Cell Biol. 7:1987;4568-4571.
13. Honegger A.M., Dull T.J., Felder S., Van Obberghen E., Bellot F., Szapary D., Schmidt A., Ullrich A., Schlessinger J. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell. 51:1987;199-209.
14. Chen W.S., Lazar C.S., Poenie M., Tsien R.Y., Gill G.N., Rosenfeld M.G. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature. 328:1987;820-823.
15. Ewald J.A., Coker K.J., Price J.O., Staros J.V., Guyer C.A. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor. Exp. Cell Res. 268:2001;262-273.
16. Daly R.J. Take your partners, please - Signal diversification by the erbB family of receptor tyrosine kinases. Growth Factors. 16:1999;255-263.
17. Earp H.S., Dawson T.L., Li X., Yu H. Heterodimerization and functional interaction between EGF receptor family members A new signaling paradigm with implications for breast cancer research . Breast Cancer Res. Treat. 35:1995;115-132.
18. Pinkas-Kramarski R., Alroy I., Yarden Y. ErbB receptors and EGF-like ligands Cell lineage determination and oncogenesis through combinatorial signaling . J. Mamm. Gland Biol. Neoplasia. 2:1997;97-107.
19. Riese D.J. 2nd, Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays. 20:1998;41-48.
20. Deb T.B., Su L., Wong L., Bonvini E., Wells A., David M., Johnson G.R. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF. J. Biol. Chem. 276:2001;15554-15560.
21. Di Fiore P.P., Segatto O., Taylor W.G., Aaronson S.A., Pierce J.H. EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science. 248:1990;79-83.
22. Pinkas-Kramarski R., Soussan L., Waterman H., Levkowitz G., Alroy I., Klapper L., Lavi S., Seger R., Ratzkin B.J., Sela M., Yarden Y. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15:1996;2452-2467.
23. Pinkas-Kramarski R., Shelly M., Guarino B.C., Wang L.M., Lyass L., Alroy I., Alimandi M., Kuo A., Moyer J.D., Lavi S., Eisenstein M., Ratzkin B.J., Seger R., Bacus S.S., Pierce J.H., Andrews G.C., Yarden Y., Alamandi M. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. Mol. Cell Biol. 18:1998;6090-6101.
24. Walker F., Kato A., Gonez L.J., Hibbs M.L., Pouliot N., Levitzki A., Burgess A.W. Activation of the Ras/mitogen-activated protein kinase pathway by kinase- defective epidermal growth factor receptors results in cell survival but not proliferation. Mol. Cell Biol. 18:1998;7192-7204.
25. Pierce J.H., Ruggiero M., Fleming T.P., Di Fiore P.P., Greenberger J.S., Varticovski L., Schlessinger J., Rovera G., Aaronson S.A. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science. 239:1988;628-631.
26. Riese D.I., van Raaij T., Plowman G., Andrews G., Stern D. The cellular response to reuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell Biol. 15:1995;5770-5776.
27. Marte B.M., Downward J. PKB/Akt Connecting phosphoinositide 3-kinase to cell survival and beyond . Trends Biochem. Sci. 22:1997;355-358.
28. Franke T.F., Kaplan D.R., Cantley L.C. PI3K Downstream AKTion blocks apoptosis . Cell. 88:1997;435-437.
29. Datta S.R., Brunet A., Greenberg M.E. Cellular survival A play in three Akts . Genes Dev. 13:1999;2905-2927.
30. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10:1998;262-267.
31. Sibilia M., Fleischmann A., Behrens A., Stingl L., Carroll J., Watt F.M., Schlessinger J., Wagner E.F. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell. 102:2000;211-220.
32. Eccles S.A. Cell biology of lymphatic metastasis. The potential role of c-erb Boncogene signalling. Rec. Results Cancer Res. 157:2000;41-54.
33. Kim H., Muller W.J. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Exp. Cell Res. 253:1999;78-87.
34. Kolibaba K.S., Druker B.J. Protein tyrosine kinases and cancer. Biochim. Biophys. Acta. 1333:1997;F217-F248.
35. Savage C.R. Jr., Cohen S. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J. Biol. Chem. 247:1972;7609-7611.
36. Wilkinson J.C., Stein R.A., Guyer C.A., Beechem J.M., Staros J.V. Real-time kinetics of ligand/cell surface receptor interactions in living cells Binding of epidermal growth factor to the epidermal growth factor receptor . Biochemistry. 40:2001;10230-10242.
37. Stein R.A., Wilkinson J.C., Guyer C.A., Staros J.V. An analytical approach to the measurement of equilibrium binding constants Application to egf binding to egf receptors in intact cells measured by flow cytometry . Biochemistry. 40:2001;6142-6154.
38. Songyang Z., Baltimore D., Cantley L.C., Kaplan D.R., Franke T.F. Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:1997;11345-11350.
39. Ormerod M.G. The study of apoptotic cells by flow cytometry. Leukemia. 12:1998;1013-1025.
40. Cheng K., Koland J.G. Nucleotide-binding properties of kinase-deficient epidermal-growth-factor-receptor mutants. Biochem. J. 330:1998;353-359.
41. Selva E., Raden D.L., Davis R.J. Mitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor. J. Biol. Chem. 268:1993;2250-2254.
42. Smulson M.E., Simbulan-Rosenthal C.M., Boulares A.H., Yakovlev A., Stoica B., Iyer S., Luo R., Haddad B., Wang Z.Q., Pang T., Jung M., Dritschilo A., Rosenthal D.S. Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1. Adv. Enzyme Regul. 40:2000;183-215.
43. Antoku K., Liu Z., Johnson D.E. IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells. Leukemia. 12:1998;682-689.
44. Stambolic V., Mak T.W., Woodgett J.R. Modulation of cellular apoptotic potential Contributions to oncogenesis . Oncogene. 18:1999;6094-6103.
45. Wright J.D., Reuter C.W., Weber M.J. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors. J. Biol. Chem. 270:1995;12085-12093.
46. Collins M.K., Downward J., Miyajima A., Maruyama K., Arai K., Mulligan R.C. Transfer of functional EGF receptors to an IL3-dependent cell line. J. Cell Physiol. 137:1988;293-298.
47. Shibuya H., Yoneyama M., Ninomiya-Tsuji J., Matsumoto K., Taniguchi T. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways Demonstration of a novel role for c-myc . Cell. 70:1992;57-67.
48. von Ruden T., Wagner E.F. Expression of functional human EGF receptor on murine bone marrow cells. EMBO J. 7:1988;2749-2756.
49. Wang H.M., Collins M., Arai K., Miyajima A. EGF induces differentiation of an IL-3-dependent cell line expressing the EGF receptor. EMBO J. 8:1989;3677-3684.
50. Hackel P.O., Zwick E., Prenzel N., Ullrich A. Epidermal growth factor receptors Critical mediators of multiple receptor pathways . Curr. Opin. Cell Biol. 11:1999;184-189.
51. Jo M., Stolz D.B., Esplen J.E., Dorko K., Michalopoulos G.K., Strom S.C. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J. Biol. Chem. 275:2000;8806-8811.
52. Kuwada S.K., Li X. Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation. Mol. Biol. Cell. 11:2000;2485-2496.
53. Leserer M., Gschwind A., Ullrich A. Epidermal growth factor receptor signal transactivation. IUBMB Life. 49:2000;405-409.
54. Luttrell L.M., Daaka Y., Lefkowitz R.J. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11:1999;177-183.
55. Roudabush F.L., Pierce K.L., Maudsley S., Khan K.D., Luttrell L.M. Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J. Biol. Chem. 275:2000;22583-22589.
56. Burtscher I., Compagni A., Lamm G.M., Christofori G. An insulin-like growth factor-mediated, phosphatidylinositol 3′ kinase-independent survival signaling in β tumor cells. Cancer Res. 59:1999;3923-3926.
57. Carson J.P., Kulik G., Weber M.J. Antiapoptotic signaling in LNCaP prostate cancer cells A survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B . Cancer Res. 59:1999;1449-1453.
58. Liu C.-B., Itoh T., Arai K., Watanabe S. Constitutive activation of JAK2 confers murine interleukin-3-independent survival and proliferation of BA/F3 cells. J. Biol. Chem. 274:1999;6342-6349.
59. Wei L., Yang Y., Yu Q. Tyrosine kinase-dependent, phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis. Cancer Res. 61:2001;2439-2444.
60. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;234-238.
61. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C., Barnard J.A., Yuspa S.H., Coffey R.J., Magnuson T. Targeted disruption of mouse EGF receptor Effect of genetic background on mutant phenotype . Science. 269:1995;230-234.
62. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376:1995;337-341.